Unknown

Dataset Information

0

Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.


ABSTRACT: Eukaryotic translation initiation factor 4 gamma 1(EIF4G1) is related to tumorigenesis and tumor progression. However, its role and the underlying mechanisms in the regulation of tumor development in non-small cell lung cancers (NSCLC) remain largely unknown. Here we report that the levels of EIF4G1 expression are much higher in NSCLC cell lines and tumor tissues than those in the normal lung cells and adjacent normal tissues from the same patients. Using shRNA to knock down EIF4G1 expression stably, we found EIF4G1 required for NSCLC cell proliferation, anchorage-independent growth, migration and invasion. Furthermore, silencing of EIF4G1 induces NSCLC cell apoptosis and causes G0/G1 cell cycle arrest. To identify the partner protein network of EIF4G1 in NSCLC cells, we found that Ubiquitin-specific protease 10 (USP10) can directly interacts with EIF4G1, while acting as a negative regulator for EIF4G1-mediated functions. Together, our results indicate that EIF4G1 functions as an oncoprotein during NSCLC development, which may represent a novel and promising therapeutic target in lung cancer.

SUBMITTER: Cao Y 

PROVIDER: S-EPMC5029698 | biostudies-other | 2016 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLC.

Cao Yueyu Y   Wei Mengdan M   Li Bing B   Liu Yali Y   Lu Ying Y   Tang Zhipeng Z   Lu Tianbao T   Yin Yujiao Y   Qin Zhiqiang Z   Xu Zengguang Z  

Oncotarget 20160401 17


Eukaryotic translation initiation factor 4 gamma 1(EIF4G1) is related to tumorigenesis and tumor progression. However, its role and the underlying mechanisms in the regulation of tumor development in non-small cell lung cancers (NSCLC) remain largely unknown. Here we report that the levels of EIF4G1 expression are much higher in NSCLC cell lines and tumor tissues than those in the normal lung cells and adjacent normal tissues from the same patients. Using shRNA to knock down EIF4G1 expression st  ...[more]

Similar Datasets

| S-EPMC121501 | biostudies-literature
| S-EPMC3251073 | biostudies-literature
| S-EPMC6717390 | biostudies-literature
| S-EPMC5494901 | biostudies-other
| S-EPMC5851622 | biostudies-literature
| S-EPMC3580022 | biostudies-literature
| S-EPMC2964218 | biostudies-literature
| S-EPMC4135593 | biostudies-literature
| S-EPMC6120211 | biostudies-literature
| S-EPMC5778534 | biostudies-literature